TScan, Ensysce top healthcare gainers; Enanta, Lexaria among losers

May 09, 2023 10:00 AM ETNVAX, ENTA, TRVN, CHRS, LEXX, ENSC, YMAB, LGVN, TCRX, GDTCBy: Ravikash, SA News Editor

Gainers: TScan Therapeutics (TCRX) +151%. Ensysce Biosciences (ENSC) +60%. Novavax (NVAX) +36%. Y-mAbs Therapeutics (YMAB) +30%. Longeveron (LGVN) +26%.
Losers: Enanta Pharmaceuticals (ENTA) -30%. Lexaria Bioscience (LEXX) -28%. Trevena (TRVN) -28%. Coherus BioSciences (CHRS) -27%. CytoMed Therapeutics (GDTC) -16%.
S&P 500 Healthcare sector is currently flat at 1,553.35. Health Care Equipment & Services is up +0.33% and Pharmaceuticals, Biotechnology & Life Sciences are down -0.24%.